Geron's share price is up $1.04 today, headed for $4, with an EPS = -0.41. They were the first ones to go trials using ESC's trials for spinal cord injuries, eventually they quit this venture and sold the business to BioTime.
Whereas ACT was the second into ESC trials for AMD & SMD, and it's share price is down today, with an EPS = -0.01. ACT's trials so far are supposedly a sucess, showing engrafment, no safety issues, and improved visual acuity. So what in hell is wrong here? In my opinion it's you Gary!
Relax man, it will be ok. I'd suggest you invest in Geron since you are so worried everyday. You will then be able to quit spending time posting remarks about Gary over here. I bet you will sleep much better.
Dunk, I already own shares of GERN stock, so I ain't going to stop bashing Gary. You should try standing up to Gary, it'll make feel better, and it beats being a wallflower afraid to say anything, eventhough you're being ripped off by a poor CEO & Chairman. Did you vote FOR the 1B share increase, too?